|
WO2021081267A1
|
|
Quinolone carboxylic derivatives
|
|
WO2021046286A1
|
|
Hepatitis b antiviral agents
|
|
CN112094224A
|
|
Preparation method of 3-substituted-5-aminopiperidine with protecting group
|
|
US2019224198A1
|
|
Cap-dependent endonuclease inhibitors
|
|
CN111208216A
|
|
Method for separating optical isomers of nemonoxacin or salt thereof
|
|
US2019047956A1
|
|
Trans-isomeric heterocyclic compounds and preparation thereof
|
|
US10004719B1
|
|
Solid dispersion formulation
|
|
CN110958880A
|
|
Solid dispersion preparation
|
|
US2016090394A1
|
|
Substituted pyrimidines for mobilizing cells expressing a type 4 CXC chemokine receptor
|
|
US2011178107A1
|
|
Hcv protease inhibitors
|
|
CN102093260A
|
|
Stereospecific synthesis of piperidine derivative
|
|
EA022785B1
|
|
Stereoselective synthesis of piperidine derivatives
|
|
TW201021855A
|
|
Lyophilization formulation
|
|
CN102058547A
|
|
Freeze-dried preparation
|
|
SG2014011258A
|
|
Hcv protease inhibitors
|
|
TW201109028A
|
|
Hcv protease inhibitors
|
|
CN102020698A
|
|
Hepatitis c virus protease inhibitor
|
|
SI2477980T1
|
|
Hcv protease inhibitors
|
|
KR20110050623A
|
|
Antibiotic drug
|
|
CN101618039A
|
|
Pneumonia treatment
|
